Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons

Neurobiology of Disease

Volumn 41, Issue 3, 2011, Pages 661-668

  Podratz, Jewel L ^a   Knight, Andrew M ^a   Ta, Lauren E ^a   Staff, Nathan P ^a   Gass, Jennifer M ^a   Genelin, Konstantin ^a   Schlattau, Alexander ^a   Lathroum, Liselle ^a   Windebank, Anthony J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chemotherapy: Neuropathy; Cisplatin; DRG neurons; Mitochondria: DNA and DNA damage

Indexed keywords

CELL NUCLEUS DNA; CISPLATIN; MITOCHONDRIAL DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASE PAIRING; BINDING AFFINITY; CELL VACUOLE; CONTROLLED STUDY; DNA DAMAGE; DRUG DNA BINDING; GENE LOCATION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL DNA REPLICATION; MITOCHONDRIAL GENE; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD NERVE CELL; SPINAL GANGLION; TRANSCRIPTION INITIATION SITE;

ANIMALS; CELLS, CULTURED; CISPLATIN; DNA DAMAGE; DNA, MITOCHONDRIAL; GANGLIA, SPINAL; MALE; MICE; MICE, INBRED C57BL; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79151482213     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.11.017     Document Type: Article

References (28)

1. Asin-Cayuela J., Gustafsson C.M. Mitochondrial transcription and its regulation in mammalian cells. Trends Biochem. Sci. 2007, 32:111-117.
2. Bottone M.G., et al. Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment. Cell Prolif. 2008, 41:506-520.
3. Cavaletti G. Peripheral neurotoxicity of platinum-based chemotherapy. Nat. Rev. Cancer 2008, 8. 1p following 71; author reply 1p following 71.
4. Clayton D.A. Replication and transcription of vertebrate mitochondrial DNA. Annu. Rev. Cell Biol. 1991, 7:453-478.
5. Conti A.M., et al. Inhibition of axonal growth from sensory neurons by excess nerve growth factor. Ann. Neurol. 1997, 42:838-846.
6. Croteau D.L., et al. Mitochondrial DNA repair pathways. Mutat. Res. 1999, 434:137-148.
7. Davis A.F., Clayton D.A. In situ localization of mitochondrial DNA replication in intact mammalian cells. J. Cell Biol. 1996, 135:883-893.
8. Eastman A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther. 1987, 34:155-166.
9. Fischer S.J., et al. Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo. Neurobiol. Dis. 2001, 8:1027-1035.
10. Fischer S.J., et al. Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia. Neurosci. Lett. 2001, 308:1-4.
11. Gill J.S., Windebank A.J. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J. Clin. Invest. 1998, 101:2842-2850.
12. Grunberg S.M., et al. Progressive paresthesias after cessation of therapy with very high-dose cisplatin. Cancer Chemother. Pharmacol. 1989, 25:62-64.
13. Knight A.M., Windebank A.J. Bax but not P53 is required for cisplatin induced cell death in rat dorsal root ganglian neurons. Program No. 225.9. 2002 Abstract Viewer/Itinerary Planner 2002, Society for Neuroscience, Washington, DC, Online.
14. Lentz S.I., et al. Mitochondrial DNA (mtDNA) Biogenesis: visualization and Duel Incorporation of BrdU and EdU Into Newly Synthesized mtDNA In Vitro. J. Histochem. Cytochem. 2010, 58:207-218.
15. Liang B.C., Ullyatt E. Increased sensitivity to cis-diamminedichloroplatinum induced apoptosis with mitochondrial DNA depletion. Cell Death Differ. 1998, 5:694-701.
16. McDonald E.S., et al. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol. Dis. 2005, 18:305-313.
17. McDonald E.S., Windebank A.J. Cisplatin-induced apoptosis of DRG neurons involves Bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol. Dis. 2002, 9:220-233.
18. Meijer C., et al. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology 1999, 20:883-887.
19. 4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res. 1995, 676:258-267.
20. Santos J.H., et al. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Meth. Mol. Biol. 2006, 314:183-199.
21. Ta L.E., et al. Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol. Pain 2010, 6:15.
22. Ta L.E., et al. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 2006, 27:992-1002.
23. Ta L.E., et al. Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli. Mol. Pain 2009, 5:9.
24. Thompson S.W., et al. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 1984, 54:1269-1275.
25. Windebank A.J., Grisold W. Chemotherapy-induced neuropathy. J. Peripher. Nerv. Syst. 2008, 13:27-46.
26. Woynarowski J.M., et al. Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. Mol. Pharmacol. 1998, 54:770-777.
27. Zhao C., et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001, 105:587-597.
28. Zuchner S., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 2004, 36:449-451.